EWSRI-CREBI is the predominant gene fusion in angiomatoid fibrous histiocytoma

Genes Chromosomes and Cancer

Volumn 46, Issue 12, 2007, Pages 1051-1060

  Antonescu, Cristina R ^a   Cin, Paola Dal ^b   Nafa, Khedoudja ^a   Teot, Lisa A ^c   Surti, Urvashi ^d   Fletcher, Christopher D ^b   Ladanyi, Marc ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFH GENE; AGED; ANGIOMATOID FIBROUS HISTIOCYTOMA; ARTICLE; ATFI GENE; CHILD; CHROMOSOME TRANSLOCATION; CLEAR CELL SARCOMA; CLINICAL ARTICLE; CREBI GENE; DERMATOFIBROMA; EWSRI AATFI GENE; EWSRI CREBI GENE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUS ATFI GENE; GASTROINTESTINAL TRACT; GENE EXPRESSION; GENE FUSION; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; GP100 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MALE; MALIGNANT TRANSFORMATION; MELANOGENESIS; MESENCHYMAL STEM CELL; MET GENE; MITF GENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOFT TISSUE SARCOMA; TFE3 GENE; CHROMOSOME ANALYSIS; GENETICS; MALIGNANT FIBROUS HISTIOCYTOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD;

CALMODULIN BINDING PROTEIN; CREB1 PROTEIN, HUMAN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EWSR1 PROTEIN, HUMAN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; CALMODULIN-BINDING PROTEINS; CHILD; CHILD, PRESCHOOL; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYTOGENETIC ANALYSIS; FEMALE; GENE EXPRESSION; GENE FUSION; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS;

EID: 35349023041     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20491     Document Type: Article

References (26)

1. Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum JR, Ladanyi M. 2001. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: A molecular and clinicopathologic study of 82 cases. Clin Cancer Res 7:3977-3987.
2. Antonescu CR, Tschernyavsky SJ, Woodruff JM, Jungbluth AA, Brennan MF, Ladanyi M. 2002. Molecular diagnosis of clear cell sarcoma: Detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases. J Mol Diagn 4:44-52.
3. Antonescu CR, Nafa K, Segal NH, Dal Cin P, Ladanyi M. 2006. EWS-CREB1: A recurrent variant fusion in clear cell sarcoma - Association with gastrointestinal location and absence of melanocytic differentiation. Clin Cancer Res 12:5356-5362.
4. Conkright MD, Montminy M. 2005. CREB: The unindicted cancer co-conspirator. Trends Cell Biol 15:457-459.
5. Costa MJ, Weiss SW. 1990. Angiomatoid malignant fibrous histiocytoma. A follow-up study of 108 cases with evaluation of possible histologic predictors of outcome. Am J Surg Pathol 14:1126-1132.
6. Davis IJ, Kim JJ, Ozsolak F, Widlund HR, Rozenblatt-Rosen O, Granter SR, Du J, Fletcher JA, Denny CT, Lessnick SL, Linehan WM, Kung AL, Fisher DE. 2006. Oncogenic MITF dysregulation in clear cell sarcoma: Defining the MiT family of human cancers. Cancer Cell 9:473-484.
7. Enzinger FM. 1979. Angiomatoid malignant fibrous histiocytoma: A distinct fibrohistiocytic tumor of children and young adults simulating a vascular neoplasm. Cancer 44:2147-2157.
8. Fanburg-Smith JC, Miettinen M. 1999. Angiomatoid "malignant" fibrous histiocytoma: A clinicopathologic study of 158 cases and further exploration of the myoid phenotype. Hum Pathol 30: 1336-1343.
9. Fletcher CD. 1991. Angiomatoid "malignant fibrous histiocytoma": An immunohistochemical study indicative of myoid differentiation. Hum Pathol 22:563-568.
10. Hallor KH, Mertens F, Jin Y, Meis-Kindblom JM, Kindblom LG, Behrendtz M, Kalen A, Mandahl N, Panagopoulos I. 2005. Fusion of the EWSR1 and ATF1 genes without expression of the MITF-M transcript in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer 44:97-102.
11. Hallor KH, Micci F, Meis-Kindblom JM, Kindblom LG, Bacchini P, Mandahl N, Mertens F, Panagopoulos I. 2007. Fusion genes in angiomatoid fibrous histiocytoma. Cancer Lett 251:158-163.
12. Kay S. 1985. Angiomatoid malignant fibrous histiocytoma. Report of two cases with ultrastructural observations of one case. Arch Pathol Lab Med 109:934-937.
13. Leu HJ, Makek M. 1982. Angiomatoid malignant fibrous histiocytoma. Case report and electron microscopic findings. Virchows Arch A Pathol Anat Histol 395:99-107.
14. Li KK, Goodall J, Goding CR, Liao SK, Wang CH, Lin YC, Hiraga H, Nojima T, Nagashima K, Schaefer KL, Lee KA. 2003. The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma. Br J Cancer 89:1072-1078.
15. McGill GG, Haq R, Nishimura EK, Fisher DE. 2006. c-Met expression is regulated by Mitf in the melanocyte lineage. J Biol Chem 281:10365-10373.
16. Panagopoulos I, Mertens F, Debiec-Rychter M, Isaksson M, Limon J, Kardas I, Domanski HA, Sciot R, Perek D, Crnalic S, Larsson O, Mandahl N. 2002. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses. Int J Cancer 99:560-567.
17. Pettinato G, Manivel JC, De Rosa G, Petrella G, Jaszcz W. 1990. Angiomatoid malignant fibrous histiocytoma: Cytologic, immunohistochemical, ultrastructural, and flow cytometric study of 20 cases. Mod Pathol 3:479-487.
18. Raddaoui E, Donner LR, Panagopoulos I. 2002. Fusion of the FUS and ATF1 genes in a large, deep-seated angiomatoid fibrous histiocytoma. Diagn Mol Pathol 11:157-162.
19. Segal NH, Pavlidis P, Noble WS, Antonescu CR, Viale A, Wesley UV, Busam K, Gallardo H, DeSantis D, Brennan MF, Cordon-Cardo C, Wolchok JD, Houghton AN. 2003. Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. J Clin Oncol 21:1775-1181.
20. Smith ME, Costa MJ, Weiss SW. 1991. Evaluation of CD68 and other histiocytic antigens in angiomatoid malignant fibrous histiocytoma. Am J Surg Pathol 15:757-763.
21. Somers GR, Viero S, Nathan PC, Teshima I, Pereira C, Zielenska M. 2005. Association of the t(12;22)(q13;q12) EWS/ATF1 rearrangement with polyphenotypic round cell sarcoma of bone: A case report. Am J Surg Pathol 29:1673-1679.
22. Sun CC, Toker C, Breitenecker R. 1982. An ultrastructural study of angiomatoid fibrous histiocytoma. Cancer 49:2103-2111.
23. Tsuda M, Davis IJ, Argani P, Shukla N, McGill GG, Nagai M, Saito T, Lae M, Fisher DE, Ladanyi M. 2007. TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition. Cancer Res 67:919-929.
24. Waters BL, Panagopoulos I, Allen EF. 2000. Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by a chromosomal translocation involving bands 12q13 and 16p11. Cancer Genet Cytogenet 121:109-116.
25. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, Best J, Chen H, Jenner R, Herbolsheimer E, Jacobsen E, Kadam S, Ecker JR, Emerson B, Hogenesch JB, Unterman T, Young RA, Montminy M. 2005. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci USA 102:4459-4464.
26. Zucman J, Delattre O, Desmaze C, Epstein AL, Stenman G, Speleman F, Fletcher CD, Aurias A, Thomas G. 1993. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 4:341-345.